Abstract Submission Guidelines & Instructions
Biomed Israel 2024 Conference Program is expanding the scope and range of topics to explore trends and innovations which are shaping the future of the healthcare system to its full extent. Each topic will consist of Invited Lectures/Panels and Company Presentations.
Important Note: Submission Deadline: 15 April 2024
Companies are invited to submit an abstract to be reviewed for oral presentation in the Company Presentation Sessions of Biomed Israel 2024.
Please ensure you read the Abstract Submission Guidelines & Instructions thoroughly prior to submission.
Important: Please add the title of your company’s Abstract/Presentation, the CEOs cell# and Email.
Presenting authors must hold one of the following positions: Chairman of the BOD, CEO, CFO, COO, CSO, VP of Business Development, VP of R&D, General Manager.
The Registration Fee for presenters of abstracts accepted to Company Presentation Sessions, will be covered for the day of the presentation and presenters will be automatically registered to the Conference. If the presenter wishes to attend the conference on any of the other 2 days, then on-line registration for any additional days must be completed.
Submission Category and Presentation Type
Abstracts for Oral Company Presentations in the Biomed Israel 2024 Conference Program must be submitted for a specific Submission Category and a specific Presentation Type. In all tracks we will feature Medical Device, Biopharma, Digital Health and Diagnosis, where appropriate.
- Submission Category (Mandatory to select one):
Accepted abstracts will be scheduled in the relevant Conference Program Track.
- Unlocking a new era in brain health innovation
- Why does cardiovascular disease remain the number ONE target for MedTech innovation?
- Digital Biomarkers & Digital Pathology: new tools to enhance therapy
- Liquid biopsy & Diagnostics: Getting closer to transforming early detection and disease management
- What can we do to make healthier aging a reality?
- Next generation of genetic medicine
- Is AI revolutionizing drug discovery and clinical development?
- Is it time to celebrate the rebound of the medical device sector?
- “NUTRItech” is the name of the game
- Evolving trends in cancer therapeutics
- The heart, the liver, the brain in concert: a year of revolutions in the cardiometabolic space
- Women’s health: cutting-edge innovation to tackle collective pain points
- Digital health role in 2024 and forward
- Hospital at home: universities ‘and hospitals’ innovations
- Israeli medical contribution to breakthrough science and technology
- Advancements in the space of bio-convergence
- Presentation Type (Mandatory to select one):
- Biotech/Pharma
- Medical Devices
- Health IT/Digital Health
- Bio Food
- Bio Convergence
- Service Providers
Abstract Template Instructions
- The Company Presentation Abstract takes the format of QUESTIONS AND RESPONSES, submitted abstracts will be evaluated on the ANSWERS to the questions. Do NOT include any other text in the document.
- Complete the abstract and save it to your computer.
- NOTE: Abstracts must be saved as a Word “*.doc” file and NOT a “*.docx” file.
- Select the Submission Category (tracks) and Presentation Type relevant to your company, i.e. Biotech/Pharma or Medical Devices or Health IT/Digital Health or Bio Food or Bio Convergence or Service Providers.
- Answers should not exceed 60 words per question.
- The minimum number of words is 100 and the maximum number of words used should not exceed 400.
- After answering the questions, leave the main bullets and delete the explanation text under each bullet.
- The abstract will now be ready for upload to the submission system.
Abstract Questions
The following questions should be answered on the abstract template. Answers should not exceed 60 words per question.
- Investment Rational
Briefly describe the company’s technology or therapeutic focus; the market opportunity, progress made to date, key partnerships or joint ventures; and management strengths. - Business Strategy
Briefly describe how the company will apply its core technology.
Generate near-term and long term revenues. - Core Technology
What is the technology, its uniqueness and its value proposition? - Product Profile/Pipeline
Describe companies’ product/pipelines, current status and market potential. Discuss milestones, potential collaboration and partnership. - What’s Next?
R&D
Preclinical / Clinicals
Organizational Plans
Financial Plans
The following questions should be answered on the abstract template. Answers should not exceed 60 words per question.
- Main Service
Briefly describe the company’s services and therapeutic areas (e.g. regulation, reimbursement, IP, etc). - Key Strengths
What is the uniqueness and key value proposition, management experience, etc? - Experience with Israeli Companies
If relevant, please provide examples. - Key Markets
In which territories are your expertise and services relevant?
For Abstract queries – please contact:
Ms. Phillipa Friedland
Office: +972-58-405-3010
